Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sentara Cardiovascular Research Institute (SCRI) is a specialized clinical research organization integrated within Sentara Health, focusing on the advancement of cardiovascular medicine. Based at the Sentara Heart Hospital in Norfolk, Virginia, the institute conducts Phase I through IV clinical trials in partnership with global pharmaceutical, biotech, and medical device companies. SCRI provides a comprehensive infrastructure for testing novel therapies in areas such as interventional cardiology, electrophysiology, and heart failure management. By bridging the gap between laboratory discovery and clinical application, the institute offers patients access to cutting-edge treatments before they are widely available. Its work is instrumental in establishing new standards of care and improving long-term outcomes for patients with complex cardiac conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sentara Cardiovascular Research Institute.